> top > docs > PubMed:18499864 > annotations

PubMed:18499864 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 36-46 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T2 51-62 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T3 138-145 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T4 138-145 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T5 322-332 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T6 334-336 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T7 343-354 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T8 622-629 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T9 622-629 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T10 631-634 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T11 686-696 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T12 777-784 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T13 777-784 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T14 1146-1148 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T15 1295-1298 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T16 1396-1398 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T17 1478-1481 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T18 1523-1525 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T19 1572-1575 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T20 1580-1582 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T21 1599-1602 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T22 1607-1609 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T23 1792-1794 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA
T24 1799-1802 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T25 1858-1861 https://glytoucan.org/Structures/Glycans/G00021MO denotes Hep
T26 1936-1938 https://glytoucan.org/Structures/Glycans/G00017MO denotes HA

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 36-46 Glycan_Motif denotes hyaluronan https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T2 51-62 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT
T3 138-145 Glycan_Motif denotes heparin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO
T5 322-332 Glycan_Motif denotes hyaluronan https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T6 334-336 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T7 343-354 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT
T8 622-629 Glycan_Motif denotes heparin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO
T10 631-634 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T11 686-696 Glycan_Motif denotes hyaluronan https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T12 777-784 Glycan_Motif denotes heparin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO
T14 1146-1148 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T15 1295-1298 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T16 1396-1398 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T17 1478-1481 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T18 1523-1525 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T19 1572-1575 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T20 1580-1582 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T21 1599-1602 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T22 1607-1609 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T23 1792-1794 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO
T24 1799-1802 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T25 1858-1861 Glycan_Motif denotes Hep https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR
T26 1936-1938 Glycan_Motif denotes HA https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 205-207 DiseaseOrPhenotypicFeature denotes CS 0008021
T2 365-367 DiseaseOrPhenotypicFeature denotes CS 0008021
T3 388-390 DiseaseOrPhenotypicFeature denotes DS 0100135
T4 1331-1333 DiseaseOrPhenotypicFeature denotes DS 0100135
T5 1335-1337 DiseaseOrPhenotypicFeature denotes CS 0008021
T6 1386-1388 DiseaseOrPhenotypicFeature denotes CS 0008021
T7 1540-1542 DiseaseOrPhenotypicFeature denotes DS 0100135
T8 1547-1549 DiseaseOrPhenotypicFeature denotes CS 0008021
T9 1940-1942 DiseaseOrPhenotypicFeature denotes CS 0008021
T10 1946-1948 DiseaseOrPhenotypicFeature denotes CS 0008021
T11 1956-1958 DiseaseOrPhenotypicFeature denotes CS 0008021

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
TextSentencer_T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
TextSentencer_T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
TextSentencer_T4 670-675 Sentence denotes 2008.
TextSentencer_T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
TextSentencer_T6 786-798 Sentence denotes J Biol Chem.
TextSentencer_T7 799-816 Sentence denotes 283:17341-17350).
TextSentencer_T8 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
TextSentencer_T9 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
TextSentencer_T10 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
TextSentencer_T11 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
TextSentencer_T12 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
TextSentencer_T13 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
TextSentencer_T14 1819-1961 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D.
TextSentencer_T15 1962-2070 Sentence denotes These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.
T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
T4 670-675 Sentence denotes 2008.
T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
T6 786-816 Sentence denotes J Biol Chem. 283:17341-17350).
T7 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
T8 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
T9 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
T10 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
T11 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
T12 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
T13 1819-2070 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D. These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.
T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
T4 670-675 Sentence denotes 2008.
T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
T6 786-798 Sentence denotes J Biol Chem.
T7 799-816 Sentence denotes 283:17341-17350).
T8 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
T9 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
T10 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
T11 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
T12 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
T13 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
T14 1819-1961 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D.
T15 1962-2070 Sentence denotes These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 36-46 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T2 51-62 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T3 138-145 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T4 138-145 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T5 322-332 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T6 343-354 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T7 622-629 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T8 622-629 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T9 686-696 https://glytoucan.org/Structures/Glycans/G00017MO denotes hyaluronan
T10 777-784 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T11 777-784 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 51-62 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
T2 343-354 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin

uniprot-human

Id Subject Object Predicate Lexical cue
T1 30-34 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T2 257-261 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T3 575-579 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T4 723-727 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T5 889-893 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T6 1187-1191 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T7 1264-1268 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T8 1310-1314 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T9 1447-1451 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T10 1778-1782 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T11 1920-1924 http://www.uniprot.org/uniprot/Q8WWQ8 denotes HARE
T12 264-274 http://www.uniprot.org/uniprot/Q8WWQ8 denotes Stabilin-2
T13 686-721 http://www.uniprot.org/uniprot/Q8WWQ8 denotes hyaluronan receptor for endocytosis
T14 205-207 http://www.uniprot.org/uniprot/O75390 denotes CS
T15 365-367 http://www.uniprot.org/uniprot/O75390 denotes CS
T16 1335-1337 http://www.uniprot.org/uniprot/O75390 denotes CS
T17 1386-1388 http://www.uniprot.org/uniprot/O75390 denotes CS
T18 1547-1549 http://www.uniprot.org/uniprot/O75390 denotes CS
T19 1940-1942 http://www.uniprot.org/uniprot/O75390 denotes CS
T20 1946-1948 http://www.uniprot.org/uniprot/O75390 denotes CS
T21 1956-1958 http://www.uniprot.org/uniprot/O75390 denotes CS
T22 334-336 http://www.uniprot.org/uniprot/P69208 denotes HA
T23 1146-1148 http://www.uniprot.org/uniprot/P69208 denotes HA
T24 1396-1398 http://www.uniprot.org/uniprot/P69208 denotes HA
T25 1523-1525 http://www.uniprot.org/uniprot/P69208 denotes HA
T26 1580-1582 http://www.uniprot.org/uniprot/P69208 denotes HA
T27 1607-1609 http://www.uniprot.org/uniprot/P69208 denotes HA
T28 1792-1794 http://www.uniprot.org/uniprot/P69208 denotes HA
T29 1936-1938 http://www.uniprot.org/uniprot/P69208 denotes HA
T30 388-390 http://www.uniprot.org/uniprot/P49366 denotes DS
T31 1331-1333 http://www.uniprot.org/uniprot/P49366 denotes DS
T32 1540-1542 http://www.uniprot.org/uniprot/P49366 denotes DS
T33 666-668 http://www.uniprot.org/uniprot/P01298 denotes PH

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 264-274 http://www.uniprot.org/uniprot/Q8R4U0 denotes Stabilin-2
T2 728-738 http://www.uniprot.org/uniprot/Q8R4U0 denotes Stabilin-2
T3 484-487 http://www.uniprot.org/uniprot/Q08761 denotes pro
T4 666-668 http://www.uniprot.org/uniprot/P10601 denotes PH

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 231-243 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for
T2 309-321 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for
T3 609-621 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for
T4 697-709 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for
T5 764-776 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for
T6 1149-1161 http://purl.bioontology.org/ontology/STY/T192 denotes receptor for

GO-BP

Id Subject Object Predicate Lexical cue
T1 63-71 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfates
T2 192-199 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T3 379-386 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T4 1360-1367 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T5 1494-1501 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T6 244-255 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T7 710-721 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T8 1073-1084 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T9 1162-1173 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T10 1621-1632 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T11 977-995 http://purl.obolibrary.org/obo/GO_0051099 denotes binding activities
T12 2020-2036 http://purl.obolibrary.org/obo/GO_0051099 denotes binding activity
T13 1636-1644 http://purl.obolibrary.org/obo/GO_0085030 denotes mutually

GO-MF

Id Subject Object Predicate Lexical cue
T1 4-10 http://purl.obolibrary.org/obo/GO_0005488 denotes ligand
T2 424-431 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T3 874-881 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T4 999-1006 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T5 1061-1068 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T6 1531-1538 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T7 2054-2061 http://purl.obolibrary.org/obo/GO_0005488 denotes ligands
T8 11-18 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T9 841-848 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T10 977-984 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T11 1299-1306 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T12 1436-1443 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T13 1610-1617 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T14 1656-1663 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T15 1862-1869 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T16 1925-1932 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T17 84-88 http://purl.obolibrary.org/obo/GO_0070026 denotes bind
T18 1783-1788 http://purl.obolibrary.org/obo/GO_0070026 denotes binds
T19 11-18 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T20 841-848 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T21 977-984 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T22 1299-1306 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T23 1436-1443 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T24 1610-1617 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T25 1656-1663 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T26 1862-1869 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T27 1925-1932 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T28 84-88 http://purl.obolibrary.org/obo/GO_0003680 denotes bind
T29 1783-1788 http://purl.obolibrary.org/obo/GO_0003680 denotes binds
T30 11-18 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T31 841-848 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T32 977-984 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T33 1299-1306 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T34 1436-1443 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T35 1610-1617 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T36 1656-1663 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T37 1862-1869 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T38 1925-1932 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T39 84-88 http://purl.obolibrary.org/obo/GO_0017091 denotes bind
T40 1783-1788 http://purl.obolibrary.org/obo/GO_0017091 denotes binds
T41 11-18 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T42 841-848 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T43 977-984 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T44 1299-1306 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T45 1436-1443 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T46 1610-1617 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T47 1656-1663 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T48 1862-1869 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T49 1925-1932 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T50 84-88 http://purl.obolibrary.org/obo/GO_0005488 denotes bind
T51 1783-1788 http://purl.obolibrary.org/obo/GO_0005488 denotes binds

GO-CC

Id Subject Object Predicate Lexical cue
T1 1105-1109 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 51-62 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T2 343-354 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T3 51-71 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin sulfates
T4 343-363 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin sulfates
T5 138-145 http://rdf.glycoinfo.org/glycan/G54161DR denotes heparin
T6 622-629 http://rdf.glycoinfo.org/glycan/G54161DR denotes heparin
T7 777-784 http://rdf.glycoinfo.org/glycan/G54161DR denotes heparin
T8 183-199 http://rdf.glycoinfo.org/glycan/G00019MO denotes dermatan sulfate
T9 370-386 http://rdf.glycoinfo.org/glycan/G00019MO denotes dermatan sulfate

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 631-634 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T2 1295-1298 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T3 1478-1481 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T4 1572-1575 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T5 1599-1602 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T6 1799-1802 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T7 1858-1861 "http://rdf.glycoinfo.org/glycan/G53038OI" denotes Hep
GlycanIUPAC_T8 631-634 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T9 1295-1298 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T10 1478-1481 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T11 1572-1575 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T12 1599-1602 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T13 1799-1802 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T14 1858-1861 "http://rdf.glycoinfo.org/glycan/G71412NI" denotes Hep
GlycanIUPAC_T15 631-634 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T16 1295-1298 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T17 1478-1481 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T18 1572-1575 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T19 1599-1602 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T20 1799-1802 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T21 1858-1861 "http://rdf.glycoinfo.org/glycan/G95181HA" denotes Hep
GlycanIUPAC_T22 631-634 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T23 1295-1298 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T24 1478-1481 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T25 1572-1575 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T26 1599-1602 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T27 1799-1802 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T28 1858-1861 "http://rdf.glycoinfo.org/glycan/G33888ZV" denotes Hep
GlycanIUPAC_T29 631-634 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T30 1295-1298 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T31 1478-1481 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T32 1572-1575 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T33 1599-1602 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T34 1799-1802 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T35 1858-1861 "http://rdf.glycoinfo.org/glycan/G72383QV" denotes Hep
GlycanIUPAC_T36 631-634 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T37 1295-1298 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T38 1478-1481 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T39 1572-1575 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T40 1599-1602 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T41 1799-1802 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T42 1858-1861 "http://rdf.glycoinfo.org/glycan/G52595WA" denotes Hep
GlycanIUPAC_T43 631-634 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T44 1295-1298 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T45 1478-1481 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T46 1572-1575 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T47 1599-1602 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T48 1799-1802 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T49 1858-1861 "http://rdf.glycoinfo.org/glycan/G65441IM" denotes Hep
GlycanIUPAC_T50 631-634 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T51 1295-1298 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T52 1478-1481 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T53 1572-1575 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T54 1599-1602 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T55 1799-1802 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T56 1858-1861 "http://rdf.glycoinfo.org/glycan/G64989KP" denotes Hep
GlycanIUPAC_T57 631-634 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T58 1295-1298 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T59 1478-1481 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T60 1572-1575 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T61 1599-1602 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T62 1799-1802 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T63 1858-1861 "http://rdf.glycoinfo.org/glycan/G39900ZC" denotes Hep
GlycanIUPAC_T64 631-634 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T65 1295-1298 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T66 1478-1481 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T67 1572-1575 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T68 1599-1602 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T69 1799-1802 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T70 1858-1861 "http://rdf.glycoinfo.org/glycan/G51147IJ" denotes Hep
GlycanIUPAC_T71 631-634 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T72 1295-1298 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T73 1478-1481 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T74 1572-1575 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T75 1599-1602 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T76 1799-1802 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep
GlycanIUPAC_T77 1858-1861 "http://rdf.glycoinfo.org/glycan/G42761PO" denotes Hep

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 51-62 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
PD-GlycoEpitope-B_T2 343-354 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 1940-1944 Disease denotes CS-A http://purl.obolibrary.org/obo/MONDO_0019569
T2 1946-1950 Disease denotes CS-C http://purl.obolibrary.org/obo/MONDO_0018616

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 51-62 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 343-354 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 51-62 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T2 343-354 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 1940-1944 Disease denotes CS-A http://purl.obolibrary.org/obo/MONDO_0019569
T2 1946-1950 Disease denotes CS-C http://purl.obolibrary.org/obo/MONDO_0018616

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 299-308 OrganismTaxon denotes scavenger 30848
T2 599-608 OrganismTaxon denotes scavenger 30848
T3 680-685 OrganismTaxon denotes human 9606
T4 2012-2019 OrganismTaxon denotes time, a 269051

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
TextSentencer_T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
TextSentencer_T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
TextSentencer_T4 670-675 Sentence denotes 2008.
TextSentencer_T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
TextSentencer_T6 786-798 Sentence denotes J Biol Chem.
TextSentencer_T7 799-816 Sentence denotes 283:17341-17350).
TextSentencer_T8 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
TextSentencer_T9 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
TextSentencer_T10 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
TextSentencer_T11 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
TextSentencer_T12 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
TextSentencer_T13 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
TextSentencer_T14 1819-1961 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D.
TextSentencer_T15 1962-2070 Sentence denotes These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.
T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
T4 670-675 Sentence denotes 2008.
T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
T6 786-816 Sentence denotes J Biol Chem. 283:17341-17350).
T7 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
T8 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
T9 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
T10 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
T11 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
T12 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
T13 1819-2070 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D. These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.
T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
T4 670-675 Sentence denotes 2008.
T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
T6 786-798 Sentence denotes J Biol Chem.
T7 799-816 Sentence denotes 283:17341-17350).
T8 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
T9 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
T10 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
T11 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
T12 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
T13 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
T14 1819-1961 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D.
T15 1962-2070 Sentence denotes These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-210 Sentence denotes The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
T2 211-546 Sentence denotes The hyaluronic acid receptor for endocytosis (HARE)/ Stabilin-2 is the primary systemic scavenger receptor for hyaluronan (HA), the chondroitin sulfates (CS), dermatan sulfate (DS), and nonglycosaminoglycan (GAG) ligands such as acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides, and advanced glycation end products.
T3 547-669 Sentence denotes We recently discovered that HARE is also a systemic scavenger receptor for heparin (Hep) (Harris EN, Weigel JA, Weigel PH.
T4 670-675 Sentence denotes 2008.
T5 676-785 Sentence denotes The human hyaluronan receptor for endocytosis [HARE/Stabilin-2] is a systemic clearance receptor for heparin.
T6 786-816 Sentence denotes J Biol Chem. 283:17341-17350).
T7 817-894 Sentence denotes Our goal was to map the binding sites of eight different ligands within HARE.
T8 895-1281 Sentence denotes We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain.
T9 1282-1526 Sentence denotes For example, Hep binding to HARE was competed by DS, CS-E, AcLDL, and dextran sulfate, but not by other CS types, HA, dextran, or heparosan. (125)I-AcLDL binding to HARE was partially competed by Hep and dextran sulfate, but not competed by HA.
T10 1527-1598 Sentence denotes Two ligands, DS and CS-E, competed with both Hep and HA to some degree.
T11 1599-1771 Sentence denotes Hep and HA binding or endocytosis is mutually inclusive; binding of these two GAGs occurs with functionally separate, noncompetitive, and apparently noninteracting domains.
T12 1772-1818 Sentence denotes Thus, HARE binds to HA and Hep simultaneously.
T13 1819-2070 Sentence denotes Although the domain(s) responsible for Hep binding remains unknown, the Link domain was required for HARE binding to HA, CS-A, CS-C, and CS-D. These results enable us to outline, for the first time, a binding activity map for multiple ligands of HARE.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 51-62 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 343-354 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 51-62 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T2 343-354 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 299-308 OrganismTaxon denotes scavenger 30848
T2 599-608 OrganismTaxon denotes scavenger 30848
T3 680-685 OrganismTaxon denotes human 9606
T4 2012-2019 OrganismTaxon denotes time, a 269051